- call +1-201-465-4211
- email sales@mrinsights.biz
Description
Scope of the Report:
The worldwide market for Hemoperfusion is expected to grow at a CAGR of roughly 17.3% over the next five years, will reach 554.8 million US$ in 2024, from 293.1 million US$ in 2019, according to a new research study.
This report focuses on the Hemoperfusion in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Jafron Biomedical
Aier
Biosun Medical
Baxter (Gambro)
Cytosorbents
Asahi-Kasei
Toray Medical
Kaneka
Zibo Kangbei
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Activated Carbon Adsorption
Resin Adsorption
Resin Adsorption takes up the largest share of the market segmentation of 76%, and is the fastest growing segment
Market Segment by Applications, can be divided into
Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others
Hepatic Encephalopathy occupies the largest market share of Hepatic Encephalopathy and is the fastest growing
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hemoperfusion product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hemoperfusion, with price, sales, revenue and global market share of Hemoperfusion in 2017 and 2018.
Chapter 3, the Hemoperfusion competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemoperfusion breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Hemoperfusion market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Hemoperfusion sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Hemoperfusion Introduction
1.2 Market Analysis by Type
1.2.1 Activated Carbon Adsorption
1.2.2 Resin Adsorption
1.3 Market Analysis by Applications
1.3.1 Hepatic Encephalopathy
1.3.2 Certain Autoimmune Diseases
1.3.3 Drug Overdose
1.3.4 Specific Intoxications
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Jafron Biomedical
2.1.1 Business Overview
2.1.2 Hemoperfusion Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Jafron Biomedical Hemoperfusion Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Aier
2.2.1 Business Overview
2.2.2 Hemoperfusion Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Aier Hemoperfusion Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Biosun Medical
2.3.1 Business Overview
2.3.2 Hemoperfusion Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biosun Medical Hemoperfusion Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Baxter (Gambro)
2.4.1 Business Overview
2.4.2 Hemoperfusion Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Baxter (Gambro) Hemoperfusion Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Cytosorbents
2.5.1 Business Overview
2.5.2 Hemoperfusion Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cytosorbents Hemoperfusion Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Asahi-Kasei
2.6.1 Business Overview
2.6.2 Hemoperfusion Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Asahi-Kasei Hemoperfusion Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Toray Medical
2.7.1 Business Overview
2.7.2 Hemoperfusion Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Toray Medical Hemoperfusion Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Kaneka
2.8.1 Business Overview
2.8.2 Hemoperfusion Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Kaneka Hemoperfusion Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Zibo Kangbei
2.9.1 Business Overview
2.9.2 Hemoperfusion Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Zibo Kangbei Hemoperfusion Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Hemoperfusion Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Hemoperfusion Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Hemoperfusion Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Hemoperfusion Manufacturer Market Share in 2018
3.3.2 Top 6 Hemoperfusion Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Hemoperfusion Market Analysis by Regions
4.1 Global Hemoperfusion Sales, Revenue and Market Share by Regions
4.1.1 Global Hemoperfusion Sales and Market Share by Regions (2014-2019)
4.1.2 Global Hemoperfusion Revenue and Market Share by Regions (2014-2019)
4.2 North America Hemoperfusion Sales and Growth Rate (2014-2019)
4.3 Europe Hemoperfusion Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Hemoperfusion Sales and Growth Rate (2014-2019)
4.5 South America Hemoperfusion Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Hemoperfusion Sales and Growth Rate (2014-2019)
5 North America Hemoperfusion by Country
5.1 North America Hemoperfusion Sales, Revenue and Market Share by Country
5.1.1 North America Hemoperfusion Sales and Market Share by Country (2014-2019)
5.1.2 North America Hemoperfusion Revenue and Market Share by Country (2014-2019)
5.2 United States Hemoperfusion Sales and Growth Rate (2014-2019)
5.3 Canada Hemoperfusion Sales and Growth Rate (2014-2019)
5.4 Mexico Hemoperfusion Sales and Growth Rate (2014-2019)
6 Europe Hemoperfusion by Country
6.1 Europe Hemoperfusion Sales, Revenue and Market Share by Country
6.1.1 Europe Hemoperfusion Sales and Market Share by Country (2014-2019)
6.1.2 Europe Hemoperfusion Revenue and Market Share by Country (2014-2019)
6.2 Germany Hemoperfusion Sales and Growth Rate (2014-2019)
6.3 UK Hemoperfusion Sales and Growth Rate (2014-2019)
6.4 France Hemoperfusion Sales and Growth Rate (2014-2019)
6.5 Russia Hemoperfusion Sales and Growth Rate (2014-2019)
6.6 Italy Hemoperfusion Sales and Growth Rate (2014-2019)
7 Asia-Pacific Hemoperfusion by Country
7.1 Asia-Pacific Hemoperfusion Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Hemoperfusion Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Hemoperfusion Revenue and Market Share by Country (2014-2019)
7.2 China Hemoperfusion Sales and Growth Rate (2014-2019)
7.3 Japan Hemoperfusion Sales and Growth Rate (2014-2019)
7.4 Korea Hemoperfusion Sales and Growth Rate (2014-2019)
7.5 India Hemoperfusion Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Hemoperfusion Sales and Growth Rate (2014-2019)
8 South America Hemoperfusion by Country
8.1 South America Hemoperfusion Sales, Revenue and Market Share by Country
8.1.1 South America Hemoperfusion Sales and Market Share by Country (2014-2019)
8.1.2 South America Hemoperfusion Revenue and Market Share by Country (2014-2019)
8.2 Brazil Hemoperfusion Sales and Growth Rate (2014-2019)
8.3 Argentina Hemoperfusion Sales and Growth Rate (2014-2019)
8.4 Colombia Hemoperfusion Sales and Growth Rate (2014-2019)
9 Middle East and Africa Hemoperfusion by Countries
9.1 Middle East and Africa Hemoperfusion Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Hemoperfusion Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Hemoperfusion Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Hemoperfusion Sales and Growth Rate (2014-2019)
9.3 Turkey Hemoperfusion Sales and Growth Rate (2014-2019)
9.4 Egypt Hemoperfusion Sales and Growth Rate (2014-2019)
9.5 Nigeria Hemoperfusion Sales and Growth Rate (2014-2019)
9.6 South Africa Hemoperfusion Sales and Growth Rate (2014-2019)
10 Global Hemoperfusion Market Segment by Type
10.1 Global Hemoperfusion Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Hemoperfusion Sales and Market Share by Type (2014-2019)
10.1.2 Global Hemoperfusion Revenue and Market Share by Type (2014-2019)
10.2 Activated Carbon Adsorption Sales Growth and Price
10.2.1 Global Activated Carbon Adsorption Sales Growth (2014-2019)
10.2.2 Global Activated Carbon Adsorption Price (2014-2019)
10.3 Resin Adsorption Sales Growth and Price
10.3.1 Global Resin Adsorption Sales Growth (2014-2019)
10.3.2 Global Resin Adsorption Price (2014-2019)
11 Global Hemoperfusion Market Segment by Application
11.1 Global Hemoperfusion Sales Market Share by Application (2014-2019)
11.2 Hepatic Encephalopathy Sales Growth (2014-2019)
11.3 Certain Autoimmune Diseases Sales Growth (2014-2019)
11.4 Drug Overdose Sales Growth (2014-2019)
11.5 Specific Intoxications Sales Growth (2014-2019)
11.6 Others Sales Growth (2014-2019)
12 Hemoperfusion Market Forecast (2019-2024)
12.1 Global Hemoperfusion Sales, Revenue and Growth Rate (2019-2024)
12.2 Hemoperfusion Market Forecast by Regions (2019-2024)
12.2.1 North America Hemoperfusion Market Forecast (2019-2024)
12.2.2 Europe Hemoperfusion Market Forecast (2019-2024)
12.2.3 Asia-Pacific Hemoperfusion Market Forecast (2019-2024)
12.2.4 South America Hemoperfusion Market Forecast (2019-2024)
12.2.5 Middle East and Africa Hemoperfusion Market Forecast (2019-2024)
12.3 Hemoperfusion Market Forecast by Type (2019-2024)
12.3.1 Global Hemoperfusion Sales Forecast by Type (2019-2024)
12.3.2 Global Hemoperfusion Market Share Forecast by Type (2019-2024)
12.4 Hemoperfusion Market Forecast by Application (2019-2024)
12.4.1 Global Hemoperfusion Sales Forecast by Application (2019-2024)
12.4.2 Global Hemoperfusion Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Hemoperfusion Picture
Table Product Specifications of Hemoperfusion
Figure Global Sales Market Share of Hemoperfusion by Types in 2018
Table Hemoperfusi
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
